The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.
Luke SteventonKenneth Keng Cheung ManShibani NicumRowan E MillerShira Peleg HassonSamixa ShahMichael BaserEmma KippsMartin D ForsterOfran AlmossawiPinkie ChambersPublished in: The oncologist (2024)
Delays to chemotherapy treatment were not significantly associated with worsened survival in patients with advanced-stage ovarian cancer. These results can inform clinical decision making that prioritize toxicity management and quality of life for those treated with chemotherapy.